30 Sept 2026, 12:56 pmInsider Trading / SAST
Closure of Trading Window
Closure of Trading Window PDF
Dolphin Medical Services Ltd operates in Healthcare Service Provider within the Healthcare sector.
15 historical price candles were omitted because the exchange source has not been verified.
Structured signal from quality, growth, valuation and momentum.
₹ crore, by fiscal year
% of revenue, by fiscal year
Comparable companies from the narrowest available industry classification.
Reported profit and loss, balance sheet, cash flow and growth history.
Annual operating, return, leverage and working-capital ratios.
Current futures and options contracts with compact option-chain pages.
Mutual-fund schemes that disclosed a holding in the company.
Annual reports, exchange filings, offer documents, ratings and earnings-call material.
Upcoming dates and the company’s corporate-action history.
Latest exchange announcements, filings and downloadable documents.
Corporate actions, results dates and filings will appear here once ingested.
Standalone figures
| Ratio | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Margins | ||||||
| Gross margin % | 91.5% | 86.5% | 85.2% | 83.8% | 84.6% | 86.7% |
| EBITDA margin % | -1,229.8% | -26.9% | -14.8% | -10.3% | 0% | 16% |
| EBIT margin % | -1,242.6% | -38.5% | -24.6% | -17.6% | -7.7% | 4% |
| PAT margin % | -66% | -36.5% | -19.7% | -14.7% | -3.9% | 5.3% |
| Working capital | ||||||
| Receivable days | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory days | 0 | 0 | 0 | 33 | 30 | 37 |
| Payable days | 0 | 0 | 0 | 0 | 0 | 0 |
| NWC days | 0 | 0 | 0 | 33 | 30 | 37 |
| Leverage | ||||||
| Current ratio | 2.96 | 2.93 | 2.97 | 2.94 | 3.41 | — |
| Debt to EBITDA | — | — | — | — | — | 7.25 |
| Debt to equity | 0.06 | 0.07 | 0.07 | 0.08 | 0.09 | 0.09 |
| Interest coverage | -29 | -16 | -11 | -8 | -2 | 7 |
| Asset turnover | 0.04 | 0.04 | 0.05 | 0.06 | 0.06 | 0.06 |
| Return ratios | ||||||
| Return on assets % | -2.5% | -1.6% | -1% | -0.8% | -0.2% | 0.3% |
| Return on capital employed % | -2.5% | -1.4% | -1% | -0.7% | -0.2% | 0.6% |
| Return on equity % | -3% | -1.8% | -1.2% | -1% | -0.3% | 0.4% |
Derived from reported annual statements. ROCE uses EBIT over capital employed (total assets less current liabilities). Day counts average the opening and closing balance; receivables turn on revenue, inventory and payables on cost of goods sold.
Only about 210 stocks have listed futures and options. Contracts appear here for those, refreshed after each close.
No scheme among the 32 fund houses on record reported a position in Dolphin Medical Services Ltd. Portfolios are published monthly by each AMC; coverage is still partial.
| Company | Mkt Cap | EV | Revenue | EBITDA | OPM | PAT | NPM | ROCE | ROE | WC Days |
|---|---|---|---|---|---|---|---|---|---|---|
| Dr. Lal Path Labs Ltd.LALPATHLABLALPATHLAB | ₹33,605 Cr | ₹33,605 Cr | ₹2,891 Cr | ₹838 Cr | 28.3% | ₹542 Cr | 18.5% | 28.8% | 21.6% | -79 |
| Vijaya Diagnostic Centre LimitedVIJAYAVIJAYA | ₹14,694 Cr | ₹14,694 Cr | ₹857 Cr | ₹362 Cr | 41.4% | ₹187 Cr | 21.3% | 21.3% | 19.7% | -117 |
| Metropolis Healthcare LimitedMETROPOLISMETROPOLIS | ₹11,151 Cr | ₹11,169 Cr | ₹1,710 Cr | ₹422 Cr | 24.4% | ₹202 Cr | 11.6% | 17.3% | 13.4% | -57 |
| Thyrocare Technologies LimitedTHYROCARETHYROCARE | ₹8,495 Cr | ₹8,495 Cr | ₹876 Cr | ₹282 Cr | 31.6% | ₹176 Cr | 19.6% | 36.5% | 28.8% | 4 |
| Nephrocare Health Services LimitedNEPHROPLUSNEPHROPLUS | ₹6,509 Cr | ₹6,589 Cr | ₹999 Cr | ₹227 Cr | 22.7% | ₹77 Cr | 7.7% | 17.1% | 9.1% | -61 |
| Suraksha Diagnostic LimitedSURAKSHASURAKSHA | ₹1,824 Cr | ₹1,826 Cr | ₹325 Cr | ₹102 Cr | 30.7% | ₹36 Cr | 10.1% | 16.8% | 14.1% | -101 |
| Krsnaa Diagnostics LimitedKRSNAAKRSNAA | ₹1,798 Cr | ₹2,332 Cr | ₹815 Cr | ₹218 Cr | 27.4% | ₹97 Cr | 13.1% | 13.1% | 10.9% | 65 |
| 3b Blackbio Dx Limited3BBLACKBIO3BBLACKBIO | ₹1,416 Cr | ₹1,417 Cr | ₹96 Cr | ₹50 Cr | 52% | ₹163 Cr | 49.4% | 25.3% | 19.4% | 235 |
| One Global Service Provider LtdONEGLOBALONEGLOBAL | ₹1,025 Cr | ₹1,025 Cr | ₹6 Cr | ₹1 Cr | 22.2% | ₹1 Cr | 17.3% | 17.6% | 19.5% | — |
| Health X Platform LimitedHEALTHXHEALTHX | ₹868 Cr | ₹890 Cr | ₹1,468 Cr | ₹-67 Cr | -4% | ₹-20 Cr | -0.1% | — | 0.2% | — |
| Gaudium Ivf And Women Health LimitedGAUDIUMIVFGAUDIUMIVF | ₹797 Cr | ₹820 Cr | ₹104 Cr | ₹38 Cr | 36.1% | ₹24 Cr | 23.4% | 23.1% | 16.1% | 92 |
| Aspira Pathlab & Diagnostics LtdASPIRAASPIRA | ₹135 Cr | ₹136 Cr | ₹22 Cr | ₹4 Cr | 16% | ₹2 Cr | 9.2% | 17.5% | 18.1% | 16 |
Documents link to external sources (exchange filings, company investor pages).
| ₹ Cr | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| 0 | 1 | 1 | 1 | 1 | 1 | |
| COGS | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross profit | 0 | 0 | 1 | 1 | 1 | 1 |
| 6 | 1 | 1 | 1 | 1 | 1 | |
| -6 | -0 | -0 | -0 | 0 | 0 | |
| OPM % | — | -26.9% | -14.8% | -10.3% | 0% | 16% |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 |
| 6 | 0 | 0 | 0 | 0 | 0 | |
| Profit before tax | -0 | -0 | -0 | -0 | -0 | 0 |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax % | 6.7% | 5.6% | 8.3% | 10% | 0% | 33.3% |
| PAT | -0 | -0 | -0 | -0 | -0 | 0 |
| PAT margin % | -66% | -36.5% | -19.7% | -14.7% | -3.9% | 5.3% |
| EPS (₹) | -0.2 | -0.1 | -0.1 | -0.1 | -0 | 0 |
| EPS adjusted (₹) | -0.2 | -0.1 | -0.1 | -0.1 | -0 | 0 |
| Annual report | Annual report for Mar 2021 | Annual report for Mar 2022 | Annual report for Mar 2023 | Annual report for Mar 2024 | Annual report for Mar 2025 | — |
| ₹ Cr | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Equity capital | 15 | 15 | 15 | 15 | 15 | 15 |
| Reserves | -5 | -5 | -5 | -5 | -5 | -5 |
| 1 | 1 | 1 | 1 | 1 | 1 | |
| 1 | 1 | 1 | 1 | 1 | 1 | |
| Total equity & liabilities | 12 | 12 | 12 | 12 | 12 | 12 |
| 3 | 3 | 3 | 3 | 3 | 3 | |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 |
| 9 | 9 | 9 | 9 | 9 | 9 | |
| Total assets | 12 | 12 | 12 | 12 | 12 | 12 |
| ₹ Cr | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| 0 | -0 | -0 | -0 | -0 | 0 | |
| 0 | 0 | 0 | 0 | 0 | -0 | |
| -0 | 0 | 0 | 0 | 0 | 0 | |
| Net cash flow | 0 | -0 | 0 | 0 | 0 | 0 |
| Free cash flow | — | — | — | -0 | -0 | -0 |
| CFO / Operating profit % | — | — | — | — | — | 116.7% |
Closure of Trading Window
Announcement under Regulation 30 (LODR)-Change in Management
Announcement under Regulation 30 (LODR)-Change in Management Control
Board Meeting Intimation for To Consider And Approve The Appointment Of Mr. Amarandhar Reddy Kotha (DIN: 07425226) As Chairman And Promoter Director Of The Company And Other Items
Board Meeting Outcome for Intimation Of Resignation Of Mr GV MOHAN PRASAD, Mrs. M LAKSHMI SUDHA And Mr. DWARAKANATH MADALA
Announcement under Regulation 30 (LODR)-Change in Management
Intimation Of Extension Of AGM
Post-Offer Advertisement
| 21 Sept 2026, 1:47 pm | Company Update Change in Management Control | Announcement under Regulation 30 (LODR)-Change in Management Control |
| 20 Sept 2026, 9:52 pm | Board Meeting | Board Meeting Intimation for To Consider And Approve The Appointment Of Mr. Amarandhar Reddy Kotha (DIN: 07425226) As Chairman And Promoter Director Of The Company And Other Items |
| 12 Sept 2026, 7:36 pm | Others Outcome without intimation | Board Meeting Outcome for Intimation Of Resignation Of Mr GV MOHAN PRASAD, Mrs. M LAKSHMI SUDHA And Mr. DWARAKANATH MADALA |
| 12 Sept 2026, 7:32 pm | Company Update Change in Management | Announcement under Regulation 30 (LODR)-Change in Management |
| 3 Sept 2026, 10:40 am | Company Update General | Intimation Of Extension Of AGM |
| 28 Aug 2026, 2:40 pm | Company Update General | Post-Offer Advertisement |
| Holder (%) | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| 26.44% | 26.44% | 26.44% | 26.44% | |
| FII | 0% | 0% | 0% | 0% |
| DII | 0% | 0% | 0% | 0% |
| Government | 0% | 0% | 0% | 0% |
| 73.56% | 73.56% | 73.56% | 73.56% | |
| No. of shareholders | 9,349 | 9,349 | 9,349 | 10,111 |
Promoter holding up 0 percentage points since Sep 2025.
Current officeholders as filed with BSE. A person holding two offices is listed once per office.